Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetic study of colistimethate sodium in Chinese adults with gram-negative bacterial infection
ChiCTR2300072099Phase 4Not yet recruiting
- Sponsor
- Tongji Hospital
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colistimethate sodium in Gram-negative bacterial infection, sponsored by Tongji Hospital. Primary endpoint: Blood concentrations of colistimethate sodium. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
colistimethate sodium
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on ChiCTR2300072099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072099.